Authors
Sanket N Fulkari, Mujibullah Sheikh, Manish P Deshmukh, Rajat Mahajan, Tejas Pimple, Isha Mirzapure
Published in
Discover nano. Volume 21. Issue 1. Jul 05, 2026. Epub Jul 05, 2026.
Abstract
Breast cancer remains the most prevalent malignancy among women worldwide, presenting significant clinical challenges due to tumor heterogeneity, multidrug resistance (MDR), and the severe systemic toxicity associated with conventional chemotherapy. In the rapidly evolving field of nanomedicine, Metal-Organic Frameworks (MOFs) have emerged as a superior class of porous nanomaterials with exceptional potential for oncology applications. Distinguished by their ultra-high surface area, tunable porosity, and biodegradable nature, MOFs offer a versatile platform for encapsulating chemotherapeutic agents, genetic materials, and photosensitizers. This review provides a comprehensive overview of the recent advancements in MOF-based nanoplatforms for the diagnosis and treatment of breast cancer. We critically analyze the synthesis and functionalization strategies that enhance the stability and targeting capability of MOFs in the physiological environment. Furthermore, we highlight the development of stimuli-responsive drug delivery systems that utilize the unique tumor microenvironment (pH, redox, and ATP) for controlled release. Finally, the review discusses the dual role of MOFs as theranostic agents integrating bioimaging (MRI, CT, and optical imaging) with therapeutic modalities (chemotherapy, photothermal, and photodynamic therapy) and outlines the future perspectives for their clinical translation.
PMID:
42402086
Bibliographic data and abstract were imported from PubMed on 05 Jul 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 9
- Comments 0